COVID 19 all comers | COVID-19 mild to moderate | COVID-19 severe or critically | ||
COVID 19 hospitalized | COVID 19 all comers | COVID-19 mild to moderate | COVID-19 severe or critically | |
neutralizing antibody | ITAC | |||
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) | ACTIV-3 ... | |||
bamlanivimab monotherapy | ACTIV-3/TICO LY-CoV555 | |||
casirivimab/imdevimab (Ronapreve) | RECOVERY ... | Somersan-Karakaya ... Suzuki | ||
cilgavimab and tixagevimab (Evusheld) | ACTIV-3/TICO ... | Chen | ||
equine polyclonal antibodies INM005 | Lopardo | |||
sotrovimab (Xevudy; VIR-7831) | ACTIV-3/ TICO ... |